- Home
- MATV vs NPCE Comparison
MATV vs NPCE Comparison
Compare MATV & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MATV
- NPCE
- Stock Information
- Founded
- MATV 1995
- NPCE 1997
- Country
- MATV United States
- NPCE United States
- Employees
- MATV N/A
- NPCE N/A
- Industry
- MATV Paper
- NPCE Medical Specialities
- Sector
- MATV Basic Materials
- NPCE Health Care
- Exchange
- MATV Nasdaq
- NPCE Nasdaq
- Market Cap
- MATV 361.1M
- NPCE 292.9M
- IPO Year
- MATV 1995
- NPCE 2021
- Fundamental
- Price
- MATV $11.62
- NPCE $8.56
- Analyst Decision
- MATV Strong Buy
- NPCE Strong Buy
- Analyst Count
- MATV 1
- NPCE 6
- Target Price
- MATV $10.00
- NPCE $16.67
- AVG Volume (30 Days)
- MATV 759.2K
- NPCE 205.8K
- Earning Date
- MATV 08-06-2025
- NPCE 08-12-2025
- Dividend Yield
- MATV 3.45%
- NPCE N/A
- EPS Growth
- MATV N/A
- NPCE N/A
- EPS
- MATV N/A
- NPCE N/A
- Revenue
- MATV $1,967,300,000.00
- NPCE $88,570,000.00
- Revenue This Year
- MATV $3.07
- NPCE $21.04
- Revenue Next Year
- MATV $2.30
- NPCE $10.73
- P/E Ratio
- MATV N/A
- NPCE N/A
- Revenue Growth
- MATV N/A
- NPCE 23.32
- 52 Week Low
- MATV $4.34
- NPCE $5.45
- 52 Week High
- MATV $19.96
- NPCE $18.98
- Technical
- Relative Strength Index (RSI)
- MATV 81.26
- NPCE 36.80
- Support Level
- MATV $6.27
- NPCE $7.56
- Resistance Level
- MATV $9.79
- NPCE $9.68
- Average True Range (ATR)
- MATV 0.61
- NPCE 0.56
- MACD
- MATV 0.49
- NPCE 0.09
- Stochastic Oscillator
- MATV 99.36
- NPCE 47.12
About MATV Mativ Holdings Inc.
Mativ Holdings Inc is a diversified producer of premium specialty papers and resin-based products. It manufactures and sells paper and reconstituted tobacco products to the tobacco industry as well as specialized paper products. The company operates in two segments namely Advanced Materials and Structures, which manufactures resin-based products used in specialty applications in the filtration, infrastructure and construction, transportation, industrial, and medical end-markets, and Engineered Papers, which produces cigarette papers and reconstituted tobacco products for cigarette and cigar manufacturers, as well as various other non-tobacco paper products.
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.